Literature DB >> 2480834

Substance P immunoreactive astrocytes are present in multiple sclerosis plaques.

S K Kostyk1, N W Kowall, S L Hauser.   

Abstract

Substance P (SP)-like immunoreactive cells were identified in postmortem white matter tissue from patients with multiple sclerosis (MS). Labelled cells, which by morphologic criteria could be identified as astrocytes, were located at the edge of both active (e.g. inflammatory) and inactive (e.g. non-inflammatory) MS lesions. By contrast, SP-immunoreactive astrocytes were not found in normal controls and were only occasionally present in other conditions associated with astrogliosis. These data suggest that SP, a potent mediator of vasodilatation and local immune responses, may play a role in the genesis of the MS plaque. These results also extend the repertoire of potential interactions which may occur between astrocytes and cells of the immune system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480834     DOI: 10.1016/0006-8993(89)91369-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Stress and multiple sclerosis: what's new?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-02-17       Impact factor: 3.282

2.  A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei.

Authors:  P G Kennedy; J Rodgers; F W Jennings; M Murray; S E Leeman; J M Burke
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.

Authors:  Chang-Jiang Guo; Steven D Douglas; Zhiyong Gao; Bryan A Wolf; Judith Grinspan; Jian-Ping Lai; Eric Riedel; Wen-Zhe Ho
Journal:  Glia       Date:  2004-11-15       Impact factor: 7.452

4.  Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression.

Authors:  Yuan Li; Steven D Douglas; David E Pleasure; Jianping Lai; Changjiang Guo; Peter Bannerman; Marge Williams; Wenzhe Ho
Journal:  J Neurosci Res       Date:  2003-02-15       Impact factor: 4.164

5.  Role of astrocytes in pathogenesis of ischemic brain injury.

Authors:  B Gabryel; H I Trzeciak
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

6.  A computational procedure for functional characterization of potential marker genes from molecular data: Alzheimer's as a case study.

Authors:  Margherita Squillario; Annalisa Barla
Journal:  BMC Med Genomics       Date:  2011-07-05       Impact factor: 3.063

7.  Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.

Authors:  C Palma; M Bigioni; C Irrissuto; F Nardelli; C A Maggi; S Manzini
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.

Authors:  Maxim Bester; Nils Daniel Forkert; Jan Patrick Stellmann; Klarissa Stürner; Lilian Aly; Anna Drabik; Kim Lea Young; Christoph Heesen; Jens Fiehler; Susanne Siemonsen
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

9.  Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis.

Authors:  Janek Vilisaar; Kiyokazu Kawabe; Manjit Braitch; Jehan Aram; Yasemin Furtun; Angela J Fahey; Mark Chopra; Radu Tanasescu; Patrick J Tighe; Bruno Gran; Charalabos Pothoulakis; Cris S Constantinescu
Journal:  J Neuroimmune Pharmacol       Date:  2015-02-18       Impact factor: 4.147

10.  Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.

Authors:  C Palma; F Nardelli; S Manzini; C A Maggi
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.